March is here, and for most people, the momentum of January has already faded. If your health goals have quietly slipped away, you're not alone — and it's not about willpower. It's about strategy.
GLP-1 receptor agonists — drugs like Ozempic, Wegovy, and Mounjaro — have transformed how we treat obesity and metabolic disease. But are they right for you? Here's what the science actually says.
Learn when IV therapy becomes the next step after supplements. Discover how IV nutrient infusions support absorption, fatigue, inflammation, and recovery through precision integrative care.
As the global conversation about climate change intensifies, its impact...